Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03306264
Title Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Indications

acute myeloid leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

Decitabine

Decitabine and Cedazuridine

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUT


No variant requirements are available.